Srilatha Edupuganti, MD
Basic profileMedical Director, Hope Clinic of Emory Vaccine Center; Associate Professor, Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine · Emory University
Srilatha Edupuganti is Medical Director, Hope Clinic of Emory Vaccine Center; Associate Professor, Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine at Emory University. OpenAlex indexes 155 publications with 12,988 citations (h-index 43); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the findmyKOL directory.
Overview
Updated 19 Oct 2026
Srilatha Edupuganti, MD, is Medical Director, Hope Clinic of Emory Vaccine Center at Emory University School of Medicine. The public record shows 156 publications with 12,986 citations (h-index 43), centered on HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, HIV/AIDS Research and Interventions. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 1 companies, 2 NIH-funded awards (2019–2026).
- Most recent indexed publication: 2026 · Science translational medicine
- Top research focus: HIV Research and Treatment
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 19 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 85.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
80 Jesse Hill Jr Dr SE
Atlanta, GA 30303-3031
Telephone
404-778-7717Registry record last updated 8 Jul 2007 · collected 28 Jul 2026.
Clinical trials
Updated 19 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Characterization of Human Memory Immune Responses to Prior Yellow Fever Vaccination
Sponsor: Emory University
Industry payments
Updated 19 Oct 2026
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20251 payment
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Glycopeptide Antibacterial51.6%Vancomycin Hcl100%Part D<11 patientsCephalosporin Antibacterial48.4%Ceftriaxone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 19 Oct 2026
2 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
- A Phase 2b randomized open label trial to assess the quality and balance of dengue immunity elicited by prime-boost combinations of TAK-003 and Butantan-DV
Emory University
FY2026$666,595U01AI186860 - A Phase 2b randomized open label trial to assess the quality and balance of dengue immunity elicited by prime-boost combinations of TAK-003 and Butantan-DV
Emory University
FY2026$317,520U01AI186860 - A Phase 2b randomized open label trial to assess the quality and balance of dengue immunity elicited by prime-boost combinations of TAK-003 and Butantan-DV
Emory University
FY2025$578,157U01AI186860
Publications
Updated 19 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost.
Science translational medicine
Article2026 - The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteins.
Science translational medicine
Article2025 - Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.
Science (New York, N.Y.)
Clinical Trial2025 - Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.
The Journal of experimental medicine
Clinical Trial2024 - Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.
Science (New York, N.Y.)
Article2020
Most-cited works
by citation count (OpenAlex)- 01Systems biological assessment of immunity to mild versus severe COVID-19 infection in humansArticle1,185 citations2020
- 02
- 03
- 04Homologous and Heterologous Covid-19 Booster VaccinationsArticle655 citations2022
- 05Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever VaccinesArticle599 citations2008
Network
Updated 19 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 19 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/srilatha-edupuganti-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
emorydailypulse.com
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →emorydailypulse.com ↗ - Other
hopeclinic.emory.edu/about/bios/edupuganti-sri.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopeclinic.emory.edu ↗ - Other
med.emory.edu/departments/medicine/divisions/infectious-diseases/profile
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.emory.edu ↗ - Other
vaccines.emory.edu/faculty-evc/affiliate/edupugnati_srilatha.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaccines.emory.edu ↗ - Other
emoryhealthcare.org/providers/srilatha-sri-edupuganti-778407
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →emoryhealthcare.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 19 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Infectious Diseases Fellowship
Emory University and University of North Carolina, Chapel Hill School of Medicine
1997verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →emoryhealthcare.org ↗ - Internal Medicine Residency
Parkland Memorial Hospital, University of Texas Southwestern Medical Center
1995verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →emoryhealthcare.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →emoryhealthcare.org ↗
- MPH in Epidemiology
University of North Carolina School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopeclinic.emory.edu ↗ - BS in Biology
Loyola University, New Orleans
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →conductscience.com ↗ - MD
Louisiana State University School of Medicine in New Orleans
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopeclinic.emory.edu ↗
Editorial & leadership roles
journal and society appointments- Member
Infectious Diseases Society of America
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →emoryhealthcare.org ↗ - Site Investigator/Co-Investigator
HIV Vaccine Trials Network (HVTN)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.emory.edu ↗ - Member
Infectious Diseases Society of America (IDSA)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ebsco.com ↗ - Co-Chair
Antibody Mediated Prevention efficacy trials (HVTN)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →conductscience.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →conductscience.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →emoryhealthcare.org ↗
- Emory Center for AIDS Research
Investigator
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaccines.emory.edu ↗ - HIV Vaccine Trials Network (HVTN)
Site Investigator/Co-investigator
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopeclinic.emory.edu ↗ - Emory Vaccine Center
Affiliate Faculty
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaccines.emory.edu ↗ - Affiliate Faculty
Emory Vaccine Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaccines.emory.edu ↗ - Investigator
Emory Center for AIDS Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaccines.emory.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
James Lah, MD
Emory University
Keith Delman, MD
Emory University
John Puskas, MD
Emory University
Craig Hofmeister, MD
Emory University
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”